Suppr超能文献

经治疗/未治疗的鞍区及鞍上区占位性病变患者对1-24促肾上腺皮质激素的血浆皮质醇反应。

Plasma cortisol response to 1-24 adrenocorticotropin in patients with treated/untreated sellar & suprasellar mass lesions.

作者信息

Bhansali A, Sreenivasulu P, Subrahmanyam K A V, Sharma B R, Dash R J

机构信息

Department of Endocrinology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.

出版信息

Indian J Med Res. 2004 May;119(5):190-4.

Abstract

BACKGROUND & OBJECTIVES: One microgram short synacthene test is widely recommended as a screening test for evaluation of hypothalamo-pituitary-adrenocortical axis in patients with secondary adrenal insufficiency. Information on adequacy of cortisol response to this dose at different periods of the day in patients with hypothalamic-pituitary disorders is not available. Hence, this study was designed to assess the adequacy of cortisol response to 1 microg 1-24 adrenocorticotropin (ACTH) at 0800 h and 1600 h in patients with sellar and suprasellar mass lesions.

METHODS

Thirty five consecutive patients with sellar and suprasellar mass lesions with mean age of 43.0+/-14.4 yr and 36 healthy controls with mean age of 32.3+/-9.0 yr were studied after obtaining informed consent. Maintenance doses of glucocorticoids in these patients were discontinued appropriately. On day 1, prestimulated and stimulated plasma cortisol samples at 0800 h and at 30 and 60 min following i.v. bolus of 1 microg 1-24 ACTH were collected. While on day 3, plasma cortisol samples were similarly collected at 1600 h. Cortisol estimation was done by a sensitive and specific radioimmunoassay. Stimulated plasma cortisol of 500 nmol/l or higher was defined as a normal response.

RESULTS

In healthy controls, the prestimulated and peak cortisol levels at 0800 h (377.5+/-93.3 and 729.1+/-183.2 nmol/l) were higher (P<0.001 and P<0.01) than those at 1600 h (230.1+/-75.7 and 665.8+/-138.6 nmol/l). All subjects had a cortisol response of 500 nmol/l or higher in response to 1 microg 1-24 ACTH both at 0800 and 1600 h. In the patients' group, the prestimulated plasma cortisol at 0800 h (250.3+/-169.7 nmol/l) was higher (P<0.001) than that at 1600 h (166.3+/-128.9 nmol/l), while the peak cortisol response was comparable (P>0.05) in the morning as well as in the evening (490.9+/-309.4 vs 464.8+/-318.4). In 27 patients (77%) the morning and evening stimulated cortisol response to 1 microg 1-24 ACTH was consistent (normal in 13 and subnormal in 14) but was discrepant in the remaining 8 (23%). In 7 of these 8 patients, cortisol response was normal at 0800 h but not at 1600 h, while in only one, normal response was seen at 1600 h but not at 0800 h.

INTERPRETATION & CONCLUSION: The demonstration of normal peak cortisol response to 1 microg 1-24 ACTH at 0800 h but not at 1600 h in substantial number of patients with sellar and suprasellar mass lesions suggests preference to morning for performing this test.

摘要

背景与目的

一微克短效促肾上腺皮质激素试验被广泛推荐用于评估继发性肾上腺皮质功能不全患者下丘脑 - 垂体 - 肾上腺皮质轴。目前尚无关于下丘脑 - 垂体疾病患者在一天中不同时段对该剂量皮质醇反应是否充分的信息。因此,本研究旨在评估鞍区和鞍上区占位性病变患者在08:00和16:00时对1微克1 - 24促肾上腺皮质激素(ACTH)的皮质醇反应是否充分。

方法

在获得知情同意后,对35例连续的鞍区和鞍上区占位性病变患者(平均年龄43.0±14.4岁)和36例健康对照者(平均年龄32.3±9.0岁)进行研究。这些患者的糖皮质激素维持剂量已适当停用。在第1天,采集08:00时以及静脉推注1微克1 - 24 ACTH后30分钟和60分钟的基础和刺激后血浆皮质醇样本。在第3天,同样在16:00时采集血浆皮质醇样本。采用灵敏且特异的放射免疫分析法测定皮质醇。刺激后血浆皮质醇≥500 nmol/l被定义为正常反应。

结果

在健康对照者中,08:00时的基础和峰值皮质醇水平(377.5±93.3和729.1±183.2 nmol/l)高于(P<0.001和P<0.01)16:00时(230.1±75.7和665.8±138.6 nmol/l)。所有受试者在08:00和16:00时对1微克1 - 24 ACTH的皮质醇反应均≥500 nmol/l。在患者组中,08:00时的基础血浆皮质醇(250.3±169.7 nmol/l)高于(P<0.001)16:00时(166.3±128.9 nmol/l),而早晨和晚上的峰值皮质醇反应相当(P>0.05)(490.9±309.4对464.8±318.4)。27例患者(77%)对1微克1 - 24 ACTH的早晨和晚上刺激后皮质醇反应一致(13例正常,14例低于正常),但其余8例(23%)不一致。在这8例患者中,7例在08:00时皮质醇反应正常但16:00时不正常,而仅1例在16:00时反应正常但08:00时不正常。

解读与结论

大量鞍区和鞍上区占位性病变患者在08:00时对1微克1 - 24 ACTH的皮质醇峰值反应正常但16:00时不正常,这表明进行该试验时更倾向于选择早晨。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验